Medicines Discovery Catapult’s Post

AMR - antimicrobial resistance is the next pandemic waiting to explode on mankind. It needs to be addressed on a war footing. The rampant use of antibiotics with no understanding of basic microbiology pharmacology pathology has brought us to this dismal situation where a saviour is now a threat. Please avoid indiscriminate use/ abuse of antibiotics. #amr #pointprevalencesurvey #asp #mrtb #xrtb #sepsis

We’re proud of our involvement with an important news-style programme, Defending our Health: Unravelling Antimicrobial Resistance, launching next week and produced by ITN Business. Hosted by Sharon Thomas from the ITN London Studio, this insightful feature will explore the urgent global threat of antibiotic resistance and include insights from some of the leading voices working hard to combat this issue. Join us next week to hear from industry and clinical experts on the vital work being done to safeguard modern medicine. #AMRAwareness #AntimicrobialResistance

This week we are announcing the winner of our Longitude Prize on Antimicrobial Resistance, which has been running for 10 years! Check out this video and stay tuned for more updates on the winner...this is a gamechanger. Challenge Works #AMR #AntimicrobialResistance #LongitudePrize #Innovation #ChallengePrizes

ICYMI: The Impact of Rapid Diagnostic Testing on CMV Detection Last year, Diasorin - Molecular's Simplexa test was highlighted for its role in detecting Cytomegalovirus (CMV) infections, a significant concern for newborns. The article emphasizes the importance of early CMV detection, especially in newborns, and the challenges associated with traditional testing methods. The Simplexa test's ability to work through both saliva and urine is a game-changer, offering a rapid and accurate alternative for CMV detection. As the healthcare industry continues to prioritize rapid diagnostic testing, innovations like the Simplexa test are crucial for improving patient outcomes and addressing prevalent yet under-recognized health threats. Read the full article here: https://lnkd.in/eFBt6mBq Remember to stay on the pulse of healthcare innovation! Join Practical Patient Care for your daily dose of essential healthcare news tailored just for you. Don't miss out – subscribe to our weekly newsletter now! 📰✨ #CMVdetection #RapidDiagnostics #NewbornHealth #HealthcareInnovation

🧫𝗪𝗼𝗿𝗹𝗱 𝗠𝗥𝗦𝗔 𝗗𝗮𝘆 MRSA (𝘔𝘦𝘵𝘩𝘪𝘤𝘪𝘭𝘭𝘪𝘯-𝘳𝘦𝘴𝘪𝘴𝘵𝘢𝘯𝘵 𝘚𝘵𝘢𝘱𝘩𝘺𝘭𝘰𝘤𝘰𝘤𝘤𝘶𝘴 𝘢𝘶𝘳𝘦𝘶𝘴) is a highly resilient bacterium and a global public health concern. In healthcare environments, MRSA spreads quickly and can lead to life-threatening infections. Patients with weakened immune systems are particularly vulnerable, and due to antibiotic resistance, treating MRSA remains a major challenge worldwide. At BioConnections, we provide laboratories and healthcare providers with innovative diagnostic tools to combat MRSA head-on. Our solutions, including Live Culture QC, Molecular QC, and LAMP-based tests, are designed for accurate, rapid results. With early detection powered by our cutting-edge diagnostics, healthcare teams can respond swiftly, ultimately improving patient outcomes and preventing further spread. Learn more about solutions here ▶ https://bit.ly/3fRaL8l #WorldMRSADay #MRSAAwareness #AntibioticResistance #InfectionPrevention #EssentialServiceLaboratories

🌍 Every year, more than 150 million women worldwide suffer from a urinary tract infection (UTI). Today, urine culture remains the gold standard for diagnosis, a practice that requires 2 to 3 urine cultures to obtain results. This results in late diagnosis and recurrent use of empirical therapy. 🦠🔍 The Sysmex PA-100 AST represents a revolution in the diagnosis of UTI, and can also play an important role in the fight against antimicrobial resistance. This innovative technology can verify the presence of a bacterial infection and specify the bacteria causing the infection in as little as 45 minutes. 👩⚕️ In less than an hour, based on the results of the analysis performed by the PA-100, clinicians can make an informed decision on the best treatment for the patient, thus rationalising the use of antibiotics and customising therapy to each case. Find out more about this technology: ⬇️ https://lnkd.in/e_r3DfWh #Sysmex #antimicrobialresistance #innovation

As Sepsis Awareness Month comes to a close, we want to emphasize that the fight against sepsis continues every day. Sepsis remains a leading cause of death worldwide, but early detection and rapid, targeted treatment can save lives. At Microbio, we’re committed to advancing diagnostics that support healthcare providers in identifying infections faster and more accurately with our innovative molecular diagnostic test, InfectID-BSI, which identifies 26 sepsis-associated pathogens, enabling clinicians to administer targeted treatment in under three hours. https://hubs.ly/Q02RttgP0 #SepsisAwareness #InfectID #HealthcareInnovation #PatientOutcomes #Microbio #PathogenDetection

🔔 Sepsis: A Global Burden 📊   Did you know that each year about 49 million people are affected by sepsis, with bacterial infections being the primary cause? Half of these infections are acquired at hospitals. Mortality in patients hospitalized for sepsis is around 25%, and in septic shock, it can be as high as 50%. 📢 Innovation in prevention and reduction of hospital acquired infections can make a difference!   🌟 At HYpharm GmbH, we are doing our part to fight against sepsis and septic shock with the clinical development of HY-133, an innovative decolonization agent for prevention of  infections caused by S. aureus including MRSA in collaboration with universitary partners in Eberhard Karls Universität Tübingen, EBERHARD-KARLS-UNIVERSITAT TUBINGEN and Universitätsmedizin Greifswald and support from Deutsches Zentrum für Infektionsforschung. Because Time to Act is Now! #WorldSepsisDay #SepsisAwarenessMonth #Sepsis Alliance

Explore this insightful article published by MDPI, which highlights the critical role of accurate diagnostics in managing infections and addressing antimicrobial resistance. Discover how the T2Bacteria Panel plays a vital role in guiding effective treatments and enhancing patient outcomes. Learn more here: ‏ https://lnkd.in/eEuTryKM 🧬💊 #AntimicrobialResistance #InfectiousDiseases #Diagnostics #HealthcareInnovation

Check out this insightful article published in MDPI on the importance of accurate diagnostics in managing infections and combating antimicrobial resistance. Learn how the T2Bacteia Panel is key in guiding effective treatments and improving patient outcomes. Read more here: https://lnkd.in/eEuTryKM 🧬💊 #AntimicrobialResistance #InfectiousDiseases #Diagnostics #HealthcareInnovation